Empirical Asset Management LLC significantly reduced its stake in Amgen Inc. by 74.6% in the third quarter, holding 1,085 shares valued at $306,000. Despite this reduction, Amgen reported strong quarterly earnings, beating estimates, and raised its quarterly dividend, reaching an intraday all-time high amidst a “Moderate Buy” analyst consensus. The company’s financials also show a solid payout ratio and a 2.7% dividend yield.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Empirical Asset Management LLC Has $306,000 Position in Amgen Inc. $AMGN
Empirical Asset Management LLC significantly reduced its stake in Amgen Inc. by 74.6% in the third quarter, holding 1,085 shares valued at $306,000. Despite this reduction, Amgen reported strong quarterly earnings, beating estimates, and raised its quarterly dividend, reaching an intraday all-time high amidst a “Moderate Buy” analyst consensus. The company’s financials also show a solid payout ratio and a 2.7% dividend yield.